The New York Times – Business:
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
The New York Times – Business:
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
The New York Times – Business:
Countries worldwide are buying more than ever from China, but domestic consumption is lagging and government stimulus efforts aren’t working.
The New York Times – Business:
Start-ups are booming in the European Union, but experts say bureaucracy keeps them from expanding across borders.
The New York Times – Business:
The Defense Department said that dozens of new reporters had agreed to sign the Pentagon’s rules on reporting, which have been rejected by many major news organizations.
The New York Times – Business:
A letter from Paramount’s chief executive, David Ellison, to Warner Bros.’ board of directors reveals weeks of talks between the two companies.
The New York Times – Business:
The company sold more cars but made less money on each one because of discounts and low-interest loans.
The New York Times – Business:
Thieves snatched jewelry valued at more than $100 million, but the museum will not be compensated for the loss.
The New York Times – Business:
The Trump administration is trying an array of unconventional measures to shore up U.S. rare earths supplies. It remains uncertain whether the strategy will work.
The New York Times – Business:
Utility rates are rising in many places across the country, and we’re continuing to report on the causes and impacts.
The New York Times – Business:
Oil prices have fallen sharply this year as global supply remains strong and demand has been slow to grow.